CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: December 12, 2006
Result type: Reports
Project Number: S0089
Product Line: Common Drug Review

Generic Name: Entecavir

Brand Name: Baraclude

Manufacturer: Bristol-Myers Squibb Canada

Indications: Hepatitis B (chronic)

Submission Type: New

Project Status: Complete

Date Recommendation Issued: November 28, 2007

Recommendation Type: List with clinical criteria and/or conditions